Yahoo Finance

Is Ascentage Pharma Group (SEHK:6855) Price Swings Creating A Valuation Opportunity Now

If you are wondering whether Ascentage Pharma Group International's current share price reflects its true worth, you are not alone. This article will walk through the key valuation clues the market is ...
Hosted on MSN

Ascentage Pharma’s Promising Clinical Study on Advanced Tumors: A Market Perspective

Ascentage Pharma Group International ((HK:6855)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and ...
Nasdaq

Ascentage Pharma Announces Clinical Data of Lisaftoclax, Which Shows Therapeutic Potential in Venetoclax-Refractory Patients, Selected for Oral Report at ASCO 2025

ROCKVILLE, Md. and SUZHOU, China, May 22, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in ...
The National Law Review

Ascentage Pharma Announces Pricing of Top-Up Placement

ROCKVILLE, Md. and SUZHOU, China, July 14, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855) (“Ascentage” or the “Company”), a global biopharmaceutical ...
Benzinga.com

Ascentage Pharma Soars On Deal With Cancer Drug Competitor

Under the partnership, Japan’s Takeda International gets an option to market Ascentage’s promising leukemia drug outside of China Without the capital infusion from Takeda, Ascentage was facing a ...
MedCity News

Ascentage Has First U.S. Biotech IPO of 2025, Raising $126M to Bring Its Cancer Meds to the World

Ascentage Pharma, a China-based drug developer with global ambitions, now has $126.4 million from a U.S. IPO that will mainly support late-stage clinical development of two medicines that could offer ...
Hosted on MSN

Ascentage Pharma to Engage Investors at December 2025 Conferences

Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Yahoo Finance

Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference

ROCKVILLE, Md. and SUZHOU, China, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage ...
Business Insider

ASH 2025 | Ascentage Pharma Presents First Dataset from Phase III POLARIS-1 Study of Olverembatinib in Newly Diagnosed Ph+ ALL Shows a Best MRD-Negativity CR Rate Exceeding 60%

ROCKVILLE, Md. and SUZHOU, China, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage ...
FierceBiotech

Obesity biotech Aardvark eyes IPO as Ascentage makes $126M Nasdaq debut

The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics revealing plans to go public while Hong Kong-listed Ascentage Pharma joins the ...
Seeking Alpha

Ascentage Pharma to Participate in Three Upcoming Investor Conferences in September 2025

ROCKVILLE, Md. and SUZHOU, China, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (AAPG) (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or ...